Drug intelligence / Profile preview

6-shogaol

Development stage
Preclinical
Lead developer
Shanghai University of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

6-shogaol is a **natural phenolic compound** formed from 6-gingerol by dehydration, and is a major bioactive principle found in dried ginger (Zingiber officinale) rhizomes. It exhibits potent anti-inflammatory and antioxidant properties. Mechanistically, 6-shogaol inhibits inflammatory signaling by downregulating pro-inflammatory cytokines (e.g. TNF, IL-1β, IL-6, IL-8), reducing nuclear factor kappa B (NFκB) activation, suppressing cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression, and modulating PI3K/Akt, MAPK, and Nrf2/ARE pathways. It is investigated mainly as a research compound and a potential dietary supplement ingredient. No drug development by pharmaceutical companies is reported; it is widely studied for its anti-inflammatory, antioxidant, neuroprotective, and anti-cancer effects[1][3].

Other names
SHOGAOL6-SHOGAOL6-ShagaolSHOGAOL 6-SHOGAOL6-SHOGAOL-6-6-gingerenol[6]-Shogaol6-Shogaol USP/EP/BP6-Shogaol-RMShogaol 10 mM in DMSOShogaol10 mM in DMSOShogaol-10 mM in DMSO
02

Targets

TXNRD2 (Thioredoxin reductase 2)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)HSP60 (60 kDa heat shock protein, mitochondrial)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)AKT (RAC-alpha serine/threonine-protein kinase)TLR4 (Toll-like receptor 4)MAPK3 (Mitogen-activated protein kinase 1)NOS2 (Nitric Oxide Synthase 2)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)NF-κBGSH (Glutathione)

Beyond the preview

Go deeper on 6-shogaol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 6-shogaol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call